UCLA scientists discover that cells contain mitochondria specialized to build fats

Mitochondria, known to most people as the “powerhouses of the cell,” have been recognized for decades as the cellular organelle where sugars and fats are oxidized to generate energy. Now, new research by UCLA scientists has found that not all mitochondria fit this definition. Within each cell a group of specialized mitochondria can be f ound attached to fat droplets. Rather than burn fat to create energy, these specialized mitochondria are responsible for providing the energy to build and store fat molecules.“This is really a whole new view of mitochondria and what they can do,” said lead author Dr. Orian Shirihai, a professor of medicine in endocrinology and pharmacology at the David Geffen School of Medicine at UCLA. The finding,published in Cell Metabolism, may one day lead to new treatments for obesity, fatty liver and other metabolic diseases, he added.Mitochondria, small organelles that are present by the hundreds or thousands inside many types of cells, contain the molecular machinery for producing ATP, the molecule that stores energy in cells. Mitochondria within any given cell have always been considered uniform, said Shirihai, because they constantly merge and separate with each other in processes known as “fusion” and “fission,” respectively.In the past, researchers have noticed — when looking at cells under a microscope — that some mitochondria associate with lipid droplets, small clumps of fatty molecule...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news

Related Links:

CONCLUSION:: To conclude, the outcomes of radiocephalic arteriovenous fistulas created by nephrologists are at par with historic outcomes. PMID: 30784345 [PubMed - as supplied by publisher]
Source: The Journal of Vascular Access - Category: Surgery Tags: J Vasc Access Source Type: research
The effect of meal on blood glucose concentration is a key issue in diabetes mellitus because its estimation could be very useful in therapy decisions. In the case of type 1 diabetes mellitus (T1DM), the therapy based on automatic insulin delivery requires a closed-loop control system to maintain euglycaemia even in the postprandial state. Thus, the mathematical modelling of glucose metabolism is relevant to predict the metabolic state of a patient. Moreover, the eating habits are characteristic of each person, so it is of interest that the mathematical models of meal intake allow to personalise the glycaemic state of the ...
Source: IET Systems Biology - Category: Biology Source Type: research
DIABETES type 2 risk could be lowered by making some diet or lifestyle changes. You could prevent high blood sugar symptoms and signs by making these small changes to your usual Chinese or Indian takeaway order.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
An MIT-led research team has developed a drug capsule -- about the size of a blueberry -- that could be used to deliver oral doses of insulin, potentially replacing the injections that people with Type 1 diabetes have to give themselves every day. In tests in animals, the researchers showed that ...This is an NSF Multimedia Gallery item.
Source: NSF Multimedia Gallery - Category: Science Source Type: video
To illustrate technique for the planned total laparoscopic hysterectomy of a morbidly obese patient with a cesarean scar ectopic pregnancy.
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Video Caf é Source Type: research
Conclusion: These data suggest that Fxr and Shp inactivation may be beneficial to combat diet‐induced obesity and uncover that hepatic SHP is necessary to promote fatty liver disease. (Hepatology 2017).
Source: Hepatology - Category: Internal Medicine Authors: Tags: Steatohepatitis and Metabolic Liver Disease Source Type: research
One of the women I work with wanted to know about the new diet drug called Belviq. The FDA is always approving a new “miracle” weight-loss pill, only to recall it a few years later. To date, at least 34 diet drugs have been taken off the market. Diet pills cause all kinds of problems — heart attack, stroke and psychiatric disorders. And Belviq isn’t any different. Some of its side effects include suicidal thoughts, a racing heartbeat, hallucinations and more… The European Union banned Belviq. The reason? It causes cancer in animals.  And here’s the real irony… Clinical tri...
Source: Al Sears, MD Natural Remedies - Category: Complementary Medicine Authors: Tags: Anti-Aging Source Type: news
Conclusions: These data suggest that Fxr and Shp inactivation may be beneficial to combat diet‐induced obesity and uncover that hepatic SHP is necessary to promote fatty liver disease. This article is protected by copyright. All rights reserved.
Source: Hepatology - Category: Internal Medicine Authors: Tags: Steatohepatitis and Metabolic Liver Disease Source Type: research
Sixty-nine percent of Americans adults are overweight, and over 35 percent are obese. Obesity increases your risk for numerous conditions including heart disease, stroke, Type 2 diabetes, high blood pressure, and cancer. Sadly, about 3.4 million adults die each year from being overweight or obese. Globally obesity now kills about the same as tobacco and all wars, terrorism and violence. Nearly all people who are overweight already have "pre-diabetes" and have significant risks of disease and death. They just don't know it. When you begin to put on weight, especially lethal belly fat, your biology shifts out of ...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Conclusion This study created a slow release version of DNP, called CRMP, that improved the way the liver processed fat and improved other measures linked to type 2 diabetes risk in rats. It did this when given for up to six weeks without the toxic side effects known to be associated with unmodified DNP. This is encouraging research, which appears to have partially tamed some of the toxic effects of DNP, while protecting its benefits. Researchers will build on this in further studies in rats and possibly people, if these results are confirmed in more studies. However, the current version of DNP that is available for sale ...
Source: NHS News Feed - Category: Consumer Health News Tags: Diabetes Medication Obesity Source Type: news
More News: Boston University | Burns | Diabetes | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Funding | Graduation | Grants | Learning | Liver | Mitochondria | National Institutes of Health (NIH) | Obesity | Students | Study | Sugar | Training | Universities & Medical Training | University of Maryland | Urology & Nephrology